Research Updates: multiple sclerosis

Below are short extracts from research updates about this subject - select more to read each item.

  1. Issue 236

    WIPFLER and COLLEAGUES, (1)Department of Neurology, Christian-Doppler-Klinik, Paracelsus Medical University  and Salzburger Landeskliniken, Ignaz-Harrer-Strasse 79, 5020, Salzburg, Austria evaluated circadian rhythmicity of inflammatory serum p1

    more..

  2. Issue 236

    ROSTI-OTAJÄRVI and HÄMÄLÄINEN, (1)Department of Neurology and Rehabilitation, Tampere University Hospital, Finland. eija.rostiotajarvi@gmail.com evaluated the prevalence of behavi1

    more..

  3. Issue 235

    GUNN and COLLEAGUES, (1)School of Health Professions, Plymouth University, Plymouth, UK evaluated the risk factors associated with falling in people with MS.

    more..

  4. Issue 235

    ZHORNITSKY and COLLEAGUES,  (1)Multiple Sclerosis Program, Department of Clinical Neurosciences, University of Calgary, Canada conducted a systematic review to examine the known associations between prolactin (PRL) and MS to elucidate its po1

    more..

  5. Issue 234

    TORKILDSEN and COLLEAGUES, (1)Department of Neurology, Norwegian Multiple Sclerosis Competence Centre, Haukeland University Hospital, Bergen, Norway conducted a systematic search for vitamins in conjunction with 'multiple sclerosis', 'animal model' 1

    more..

  6. Issue 234

    MESLINIENE and COLLEAGUES, (1)Division of Endocrinology, University of Florida College of Medicine-Jacksonville, Jacksonville, FL 32209, USA set out to review and assess the role of vitamin D in multiple sclerosis (MS).

    more..

  7. Issue 234

    MARTÍNEZ-SERNÁNDEZ and COLLEAGUES, (1)Department of Microbiology and Parasitology, Faculty of Pharmacy, University of Santiago de Compostela, 15782, Santiago de Compostela, Spain. victoria.ma1

    more..

  8. Issue 232

    KAPLAN and COLLEAGUES, (1)Heller Institute of Medical Research, Sheba Medical Center, Tel-Hashomer, Israel. batiakaplan@gmail.com the authors, in the search for new biomarkers for multiple sclerosis (MS), c1

    more..

  9. Issue 232

    EVANS and COLLEAGUES,  (1)Division of Neurology, University of British Columbia, Vancouver, B.C., Canada. charity.evans@usask.ca conducted a comprehensive review examining the incidence and prevalenc1

    more..

  10. Issue 231

    ADELMAN and COLLEAGUES, (1)Fielding School of Public Health, University of California, Los Angeles, CA, USA estimate average annual cost per multiple sclerosis (MS) patient in the US using published estimates from the literature.

    more..

  11. Issue 230

    COSSU and COLLEAGUES, (1)Dipartimento di Scienze Biomediche, Sezione di Microbiologia Sperimentale e Clinica, Università di Sassari, Italy. davide.cossu@email.it conducted a clinical trial to study r1

    more..

  12. Issue 230

    MERO and COLLEAGUES,  (1)Department of Neurology, Oslo University Hospital, Ullevål, and Department of Medical Genetics, University of Oslo, Oslo, Norway searched for genetic differences in multiple sclerosis (MS) relating to the prese1

    more..

  13. Issue 230

    LIN and COLLEAGUES,  (1)Menzies Research Institute Tasmania, University of Tasmania, Hobart, Australia searched for rare MS variants utilizing identity-by-descent (IBD) mapping in a large genome-wide association studies (GWAS) dataset.

    more..

  14. Issue 230

    AMATYA and COLLEAGUES, (1)Department of Rehabilitation Medicine, Royal Melbourne Hospital, Royal Park Campus, Melbourne, Australia. Bhasker.Amatya@mh.org.au assessed the effectiveness of various non-pharmacological interventions for the treatment1

    more..

  15. Issue 229

    FERNANDEZ and COLLEAGUES,  (1)Hospital Universitario Carlos Haya, 29190 Malaga, Spain. oscar.fernandez.sspa@juntadeandalucia.es reviewed information regarding biomarkers in multiple 1

    more..

  16. Issue 228

    YUSUF and KOSKI, (1)Integrated Program in Neuroscience, McGill University, Montreal, QC H3A 1A1, Canada. afiqah.yusuf@mail.mcgill.ca conducted a qualitative review to test the hypothesis that changes 1

    more..

  17. Issue 228

    BUSTAMANTE and COLLEAGUES, (1)Servei de Neurología/Neuroimmunología. Centre d'Esclerosi Múltiple de Catalunya,  Cemcat. Hospital Universitari Vall dHebron (HUVH), Barcelona, Spain investigated whether the type I interfer1

    more..

  18. Issue 228

    HAWTON and COLLEAGUES, (1)Health Economics Group, University of Exeter Medical School, University of Exeter, Exeter, UK. a.hawton@exeter.ac.uk set out to identify all published economic evaluations of MS t1

    more..

  19. Issue 227

    KOLASA, Centre for Pharmacoeconomics, University of Warsaw. kkolasa@wum.edu.pl conducted a systematic review of cost of illness studies to estimate the average annual cost of MS patient and its breakdown.

    more..

  20. Issue 227

    REYES and COLLEAGUES, (1)School of Medical Sciences, Edith Cowan University, Joondalup, WA, Australia. a.reyes@ecu.edu.au assessed evidence regarding the efficacy of inspiratory muscle training (IMT) and ex1

    more..

« Prev 1 2

Munro Hall Clinic 2017

IJCA-EORC-Botanica-2016b

Scientific and Medical Network 2

The Big Heart Bike Ride Costa Rica 2018

Snowdonia Charity Challenge 2018

top of the page